Status Approved
First Submitted Date
2020/05/20
Registered Date
2020/05/21
Last Updated Date
2020/05/21
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0005047 |
---|---|
Unique Protocol ID | 2016-0463 |
Public/Brief Title | Comparison of the postoperative pain intensity and complications following different anesthetic techniques during thyroidectomy |
Scientific Title | Comparison of the postoperative pain intensity and complications following different anesthetic techniques during thyroidectomy |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | 2016-0463 |
Approval Date | 2016-05-04 |
Institutional Review Board Name | the Institutional Review Board of Asan Medical Center |
Institutional Review Board Address | 88, Olympic-ro 43-gil, Songpa-gu, Seoul |
Institutional Review Board Telephone | 02-3010-7166 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Seung-Woo Ku |
Title | Professor |
Telephone | +82-2-3010-3868 |
Affiliation | Asan Medical Center |
Address | 88 Olympic-ro 43 gil, Sonpa-gu, Seoul |
Contact Person for Public Queries | |
Name | Jun-Young Jo |
Title | Assistant Professor |
Telephone | +82-2-3010-3868 |
Affiliation | Asan Medical Center |
Address | 88 Olympic-ro 43 gil, Sonpa-gu, Seoul |
Contact Person for Updating Information | |
Name | Jun-Young Jo |
Title | Assistant Professor |
Telephone | +82-2-3010-3868 |
Affiliation | Asan Medical Center |
Address | 88 Olympic-ro 43 gil, Sonpa-gu, Seoul |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2016-05-13 Actual | |
Target Number of Participant | 80 | |
Primary Completion Date | 2016-11-18 , Actual | |
Study Completion Date | 2017-04-24 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Asan Medical Center | |
Recruitment Status | Completed | |
Date of First Enrollment | 2016-05-13 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Asan Medical Center |
Organization Type | Medical Institute |
Project ID | 2016-0463 |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Asan Medical Center |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Continuous remifentanil infusion during general anesthesia effectively and easily maintains vitals. However, high pain levels and increased demand for postoperative analgesics in the early postoperative period are often encountered. This study investigated pain intensity and the need for rescue analgesics in the immediate postoperative period in patients after total intravenous anesthesia with remifentanil compared with intravenous induction and volatile maintenance anesthesia. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Supportive Care |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Subject, Outcome Accessor |
Allocation | RCT |
Intervention Type | Others |
Intervention Description | Each patient was randomly assigned to the TIVA (total intravenous anesthesia) or VA (volatile anesthesia) group. |
Number of Arms | 2 |
Arm 1 |
Arm Label volatile anesthesia |
Target Number of Participant 40 |
|
Arm Type Active comparator |
|
Arm Description Maintain anesthesia using only inhaled anesthetic agents without remifentanil infusion after induction of general anesthesia. |
|
Arm 2 |
Arm Label total intravenous anesthsia |
Target Number of Participant 40 |
|
Arm Type Experimental |
|
Arm Description After general anesthesia is induced, general anesthesia is maintained by intravenous anesthesia using propofol and remifentanil. Remifentanil is infused by target-controlled infusion method and remifentanil was titrated to maintain the patient’s baseline blood pressure within 20%. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (E00-E90)Endocrine, nutritional and metabolic diseases (E07.9)Disorder of thyroid, unspecified thyroid disease which needs thyroidectomy |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 20Year~79Year |
|
Description We included patients from 20–79 years of age with American Society of Anesthesiologists physical status I-III and who were undergoing elective thyroid surgery by the same surgeon. |
|
Exclusion Criteria |
history of allergy or contraindication to opioids or non-steroidal anti-inflammatory agents (NSAIDs); severe renal dysfunction with limited use of NSAIDs; bronchial asthma; psychiatric disease; intake of opioids within 1 month before surgery or any analgesics 6 hours before surgery; reoperation on thyroid; or simultaneous radical neck lymph node dissection or other surgeries. |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Not applicable | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | the intensity of postoperative pain |
|
Timepoint | arrival to post-anesthetic care unit, 30 min after surgery, and 60 min after surgery |
|
Secondary Outcome(s) 1 | ||
Outcome | Morphine equianalgesic doses (MED) |
|
Timepoint | during stay at post-anesthetic care unit |
|
Secondary Outcome(s) 2 | ||
Outcome | changes of vital sign during surgery |
|
Timepoint | induction of anesthesia to skin incision |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동